title: Transplantation of solid organs procured from influenza A H1N1 infected donors.
abstract: Following the influenza A H1N1 (swine flu) pandemic, there remains little evidence informing the safety of transplanting organs from donors suspected or diagnosed with H1N1. Limited guidelines from the major transplant societies leave the use of such organs at the discretion of individual transplant centres, and practice varies considerably both nationally and internationally. We present the largest published series of outcome following transplantation of organs from H1N1 positive donors and demonstrate that these organs can be transplanted safely and with good short-term outcome. We discuss our local policy for treatment of recipients with Oseltamivir.
authors.affiliation: Department of Transplantation, Division of Surgery, St James' University Hospital, Leeds, UK.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Cockbain
authors.forename: Matthew
authors.initials: M
authors.lastname: Jacob
authors.forename: Clare
authors.initials: C
authors.lastname: Ecuyer
authors.forename: Lutz
authors.initials: L
authors.lastname: Hostert
authors.forename: Niaz
authors.initials: N
authors.lastname: Ahmad
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission*; D016030:Kidney Transplantation; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D053139:Oseltamivir / Q000627:therapeutic use; D014019:Tissue Donors; D009927:Tissue and Organ Procurement / Q000379:methods*; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir